东诚药业：2025年前三季度净利润约1.49亿元

Group 1 - Dongcheng Pharmaceutical reported a revenue of approximately 2.043 billion yuan for the first three quarters of 2025, a year-on-year decrease of 5.52% [1] - The net profit attributable to shareholders of the listed company was approximately 149 million yuan, a year-on-year decrease of 10.64% [1] - Basic earnings per share were 0.1808 yuan, reflecting a year-on-year decrease of 10.67% [1] Group 2 - As of the report, Dongcheng Pharmaceutical has a market capitalization of 12.6 billion yuan [2]